Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Department of Error] Department of Error

Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet 2017; 389: 2239–51—In this Seminar, a correction of “type 2 diabetes” to “type 1 diabetes” has been made to the second sentence of the last paragraph in the Challenges in optimisation and maintenance of glycaemic control section: “Diagnosis and differentiation from type 1 diabetes is based on identifying markers of insulin resistance, such as acanthosis nigricans, and results of biochemical tests, including high C-peptide concentrations and absence of autoantibodies.” This correction has been made to the online version as of Feb 21, 2017, and the printed Seminar is correct.